Aspiration and Biopsy Needles
The global Aspiration and Biopsy Needles market is segmented by company, region (country), , and ... Read More
1 Parenteral Drugs Market Overview 1.1 Parenteral Drugs Product Scope 1.2 Parenteral Drugs Segment 1.2.1 Global Parenteral Drugs Sales (2016 & 2021 & 2027) 1.2.2 LVP Drug 1.2.3 SVP Drug 1.3 Parenteral Drugs Segment 1.3.1 Global Parenteral Drugs Sales Comparison (2016 & 2021 & 2027) 1.3.2 Hospitals 1.3.3 Medical Centers 1.3.4 Others 1.4 Parenteral Drugs Market Estimates and Forecasts (2016-2027) 1.4.1 Global Parenteral Drugs Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Parenteral Drugs Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Parenteral Drugs Price Trends (2016-2027) 2 Parenteral Drugs Estimates and Forecasts by Region 2.1 Global Parenteral Drugs Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Parenteral Drugs Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Parenteral Drugs Sales Market Share by Region (2016-2021) 2.2.2 Global Parenteral Drugs Revenue Market Share by Region (2016-2021) 2.3 Global Parenteral Drugs Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Parenteral Drugs Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Parenteral Drugs Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Parenteral Drugs Estimates and Projections (2016-2027) 2.4.2 Europe Parenteral Drugs Estimates and Projections (2016-2027) 2.4.3 China Parenteral Drugs Estimates and Projections (2016-2027) 2.4.4 Japan Parenteral Drugs Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Parenteral Drugs Estimates and Projections (2016-2027) 2.4.6 India Parenteral Drugs Estimates and Projections (2016-2027) 3 Global Parenteral Drugs Competition Landscape by Players 3.1 Global Top Parenteral Drugs Players by Sales (2016-2021) 3.2 Global Top Parenteral Drugs Players by Revenue (2016-2021) 3.3 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parenteral Drugs as of 2020) 3.4 Global Parenteral Drugs Average Price by Company (2016-2021) 3.5 Manufacturers Parenteral Drugs Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Parenteral Drugs Market Size 4.1 Global Parenteral Drugs Historic Market Review (2016-2021) 4.1.1 Global Parenteral Drugs Sales Market Share (2016-2021) 4.1.2 Global Parenteral Drugs Revenue Market Share (2016-2021) 4.1.3 Global Parenteral Drugs Price (2016-2021) 4.2 Global Parenteral Drugs Market Estimates and Forecasts (2022-2027) 4.2.1 Global Parenteral Drugs Sales Forecast (2022-2027) 4.2.2 Global Parenteral Drugs Revenue Forecast (2022-2027) 4.2.3 Global Parenteral Drugs Price Forecast (2022-2027) 5 Global Parenteral Drugs Market Size 5.1 Global Parenteral Drugs Historic Market Review (2016-2021) 5.1.1 Global Parenteral Drugs Sales Market Share (2016-2021) 5.1.2 Global Parenteral Drugs Revenue Market Share (2016-2021) 5.1.3 Global Parenteral Drugs Price (2016-2021) 5.2 Global Parenteral Drugs Market Estimates and Forecasts (2022-2027) 5.2.1 Global Parenteral Drugs Sales Forecast (2022-2027) 5.2.2 Global Parenteral Drugs Revenue Forecast (2022-2027) 5.2.3 Global Parenteral Drugs Price Forecast (2022-2027) 6 North America Parenteral Drugs Market Facts & Figures 6.1 North America Parenteral Drugs Sales by Company 6.1.1 North America Parenteral Drugs Sales by Company (2016-2021) 6.1.2 North America Parenteral Drugs Revenue by Company (2016-2021) 6.2 North America Parenteral Drugs Sales Breakdown 6.2.1 North America Parenteral Drugs Sales Breakdown (2016-2021) 6.2.2 North America Parenteral Drugs Sales Breakdown (2022-2027) 6.3 North America Parenteral Drugs Sales Breakdown 6.3.1 North America Parenteral Drugs Sales Breakdown (2016-2021) 6.3.2 North America Parenteral Drugs Sales Breakdown (2022-2027) 7 Europe Parenteral Drugs Market Facts & Figures 7.1 Europe Parenteral Drugs Sales by Company 7.1.1 Europe Parenteral Drugs Sales by Company (2016-2021) 7.1.2 Europe Parenteral Drugs Revenue by Company (2016-2021) 7.2 Europe Parenteral Drugs Sales Breakdown 7.2.1 Europe Parenteral Drugs Sales Breakdown (2016-2021) 7.2.2 Europe Parenteral Drugs Sales Breakdown (2022-2027) 7.3 Europe Parenteral Drugs Sales Breakdown 7.3.1 Europe 140 Sales Breakdown (2016-2021) 7.3.2 Europe 140 Sales Breakdown (2022-2027) 8 China Parenteral Drugs Market Facts & Figures 8.1 China Parenteral Drugs Sales by Company 8.1.1 China Parenteral Drugs Sales by Company (2016-2021) 8.1.2 China Parenteral Drugs Revenue by Company (2016-2021) 8.2 China Parenteral Drugs Sales Breakdown 8.2.1 China Parenteral Drugs Sales Breakdown (2016-2021) 8.2.2 China Parenteral Drugs Sales Breakdown (2022-2027) 8.3 China Parenteral Drugs Sales Breakdown 8.3.1 China 313 Sales Breakdown (2016-2021) 8.3.2 China 313 Sales Breakdown (2022-2027) 9 Japan Parenteral Drugs Market Facts & Figures 9.1 Japan Parenteral Drugs Sales by Company 9.1.1 Japan Parenteral Drugs Sales by Company (2016-2021) 9.1.2 Japan Parenteral Drugs Revenue by Company (2016-2021) 9.2 Japan Parenteral Drugs Sales Breakdown 9.2.1 Japan Parenteral Drugs Sales Breakdown (2016-2021) 9.2.2 Japan Parenteral Drugs Sales Breakdown (2022-2027) 9.3 Japan Parenteral Drugs Sales Breakdown 9.3.1 Japan Feb. Sales Breakdown (2016-2021) 9.3.2 Japan Feb. Sales Breakdown (2022-2027) 10 Southeast Asia Parenteral Drugs Market Facts & Figures 10.1 Southeast Asia Parenteral Drugs Sales by Company 10.1.1 Southeast Asia Parenteral Drugs Sales by Company (2016-2021) 10.1.2 Southeast Asia Parenteral Drugs Revenue by Company (2016-2021) 10.2 Southeast Asia Parenteral Drugs Sales Breakdown 10.2.1 Southeast Asia Parenteral Drugs Sales Breakdown (2016-2021) 10.2.2 Southeast Asia Parenteral Drugs Sales Breakdown (2022-2027) 10.3 Southeast Asia Parenteral Drugs Sales Breakdown 10.3.1 Southeast Asia K Units Sales Breakdown (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown (2022-2027) 11 India Parenteral Drugs Market Facts & Figures 11.1 India Parenteral Drugs Sales by Company 11.1.1 India Parenteral Drugs Sales by Company (2016-2021) 11.1.2 India Parenteral Drugs Revenue by Company (2016-2021) 11.2 India Parenteral Drugs Sales Breakdown 11.2.1 India Parenteral Drugs Sales Breakdown (2016-2021) 11.2.2 India Parenteral Drugs Sales Breakdown (2022-2027) 11.3 India Parenteral Drugs Sales Breakdown 11.3.1 India Parenteral Drugs Sales Breakdown (2016-2021) 11.3.2 India Parenteral Drugs Sales Breakdown (2022-2027) 12 Company Profiles and Key Figures in Parenteral Drugs Business 12.1 Ostuka Pharmaceutical 12.1.1 Ostuka Pharmaceutical Corporation Information 12.1.2 Ostuka Pharmaceutical Business Overview 12.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered 12.1.5 Ostuka Pharmaceutical Recent Development 12.2 Teva Pharmaceutical Industries 12.2.1 Teva Pharmaceutical Industries Corporation Information 12.2.2 Teva Pharmaceutical Industries Business Overview 12.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Teva Pharmaceutical Industries Parenteral Drugs Products Offered 12.2.5 Teva Pharmaceutical Industries Recent Development 12.3 Kelun Pharma 12.3.1 Kelun Pharma Corporation Information 12.3.2 Kelun Pharma Business Overview 12.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Kelun Pharma Parenteral Drugs Products Offered 12.3.5 Kelun Pharma Recent Development 12.4 Cook Pharmica 12.4.1 Cook Pharmica Corporation Information 12.4.2 Cook Pharmica Business Overview 12.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Cook Pharmica Parenteral Drugs Products Offered 12.4.5 Cook Pharmica Recent Development 12.5 Patheon 12.5.1 Patheon Corporation Information 12.5.2 Patheon Business Overview 12.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Patheon Parenteral Drugs Products Offered 12.5.5 Patheon Recent Development 12.6 BAG Healthcare 12.6.1 BAG Healthcare Corporation Information 12.6.2 BAG Healthcare Business Overview 12.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 BAG Healthcare Parenteral Drugs Products Offered 12.6.5 BAG Healthcare Recent Development 12.7 Beximco Pharma 12.7.1 Beximco Pharma Corporation Information 12.7.2 Beximco Pharma Business Overview 12.7.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Beximco Pharma Parenteral Drugs Products Offered 12.7.5 Beximco Pharma Recent Development 12.8 Baxter Healthcare Corporation 12.8.1 Baxter Healthcare Corporation Corporation Information 12.8.2 Baxter Healthcare Corporation Business Overview 12.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Baxter Healthcare Corporation Parenteral Drugs Products Offered 12.8.5 Baxter Healthcare Corporation Recent Development 12.9 B. Braun 12.9.1 B. Braun Corporation Information 12.9.2 B. Braun Business Overview 12.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 B. Braun Parenteral Drugs Products Offered 12.9.5 B. Braun Recent Development 12.10 Fresenius 12.10.1 Fresenius Corporation Information 12.10.2 Fresenius Business Overview 12.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Fresenius Parenteral Drugs Products Offered 12.10.5 Fresenius Recent Development 12.11 Albert David 12.11.1 Albert David Corporation Information 12.11.2 Albert David Business Overview 12.11.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Albert David Parenteral Drugs Products Offered 12.11.5 Albert David Recent Development 12.12 BML Parenteral Drugs 12.12.1 BML Parenteral Drugs Corporation Information 12.12.2 BML Parenteral Drugs Business Overview 12.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.12.4 BML Parenteral Drugs Parenteral Drugs Products Offered 12.12.5 BML Parenteral Drugs Recent Development 12.13 Pfizer (Hospira) 12.13.1 Pfizer (Hospira) Corporation Information 12.13.2 Pfizer (Hospira) Business Overview 12.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Pfizer (Hospira) Parenteral Drugs Products Offered 12.13.5 Pfizer (Hospira) Recent Development 12.14 Pisa 12.14.1 Pisa Corporation Information 12.14.2 Pisa Business Overview 12.14.3 Pisa Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Pisa Parenteral Drugs Products Offered 12.14.5 Pisa Recent Development 12.15 Ozon Pharmaceuticals Ltd 12.15.1 Ozon Pharmaceuticals Ltd Corporation Information 12.15.2 Ozon Pharmaceuticals Ltd Business Overview 12.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Products Offered 12.15.5 Ozon Pharmaceuticals Ltd Recent Development 12.16 Aspen Holdings 12.16.1 Aspen Holdings Corporation Information 12.16.2 Aspen Holdings Business Overview 12.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Aspen Holdings Parenteral Drugs Products Offered 12.16.5 Aspen Holdings Recent Development 12.17 PSI Ltd 12.17.1 PSI Ltd Corporation Information 12.17.2 PSI Ltd Business Overview 12.17.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.17.4 PSI Ltd Parenteral Drugs Products Offered 12.17.5 PSI Ltd Recent Development 12.18 Wintac Limited 12.18.1 Wintac Limited Corporation Information 12.18.2 Wintac Limited Business Overview 12.18.3 Wintac Limited Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Wintac Limited Parenteral Drugs Products Offered 12.18.5 Wintac Limited Recent Development 12.19 AXA Parenterals Ltd 12.19.1 AXA Parenterals Ltd Corporation Information 12.19.2 AXA Parenterals Ltd Business Overview 12.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.19.4 AXA Parenterals Ltd Parenteral Drugs Products Offered 12.19.5 AXA Parenterals Ltd Recent Development 12.20 Acebright 12.20.1 Acebright Corporation Information 12.20.2 Acebright Business Overview 12.20.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Acebright Parenteral Drugs Products Offered 12.20.5 Acebright Recent Development 12.21 Southwest Pharmaceutical 12.21.1 Southwest Pharmaceutical Corporation Information 12.21.2 Southwest Pharmaceutical Business Overview 12.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Southwest Pharmaceutical Parenteral Drugs Products Offered 12.21.5 Southwest Pharmaceutical Recent Development 12.22 Abbott 12.22.1 Abbott Corporation Information 12.22.2 Abbott Business Overview 12.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Abbott Parenteral Drugs Products Offered 12.22.5 Abbott Recent Development 13 Parenteral Drugs Manufacturing Cost Analysis 13.1 Parenteral Drugs Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Parenteral Drugs 13.4 Parenteral Drugs Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Parenteral Drugs Distributors List 14.3 Parenteral Drugs Customers 15 Market Dynamics 15.1 Parenteral Drugs Market Trends 15.2 Parenteral Drugs Drivers 15.3 Parenteral Drugs Market Challenges 15.4 Parenteral Drugs Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer
List of Tables Table 1. Global Parenteral Drugs Sales (US$ Million) Growth Rate (2016 & 2021 & 2027) Table 2. Global Parenteral Drugs Sales ((US$ Million)) Comparison (2016 & 2021 & 2027) Table 3. Global Parenteral Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Parenteral Drugs Sales (K Units) by Region (2016-2021) Table 5. Global Parenteral Drugs Sales Market Share by Region (2016-2021) Table 6. Global Parenteral Drugs Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Parenteral Drugs Revenue Share by Region (2016-2021) Table 8. Global Parenteral Drugs Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Parenteral Drugs Sales Market Share Forecast by Region (2022-2027) Table 10. Global Parenteral Drugs Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Parenteral Drugs Revenue Share Forecast by Region (2022-2027) Table 12. Global Parenteral Drugs Sales (K Units) of Key Companies (2016-2021) Table 13. Global Parenteral Drugs Sales Share by Company (2016-2021) Table 14. Global Parenteral Drugs Revenue (US$ Million) by Company (2016-2021) Table 15. Global Parenteral Drugs Revenue Share by Company (2016-2021) Table 16. Global Parenteral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2020) Table 17. Global Parenteral Drugs Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers Parenteral Drugs Manufacturing Sites and Area Served Table 19. Manufacturers Parenteral Drugs Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Parenteral Drugs Sales (K Units) (2016-2021) Table 22. Global Parenteral Drugs Sales Share (2016-2021) Table 23. Global Parenteral Drugs Revenue (US$ Million) Market Share (2016-2021) Table 24. Global Parenteral Drugs Price (USD/Unit) (2016-2021) Table 25. Global Parenteral Drugs Sales Share (2022-2027) Table 26. Global Parenteral Drugs Revenue (US$ Million) Market Share (2022-2027) Table 27. Global Parenteral Drugs Revenue Share (2022-2027) Table 28. Global Parenteral Drugs Price (USD/Unit) (2022-2027) Table 29. Global Parenteral Drugs Sales (K Units) (2016-2021) Table 30. Global Parenteral Drugs Sales Share (2016-2021) Table 31. Global Parenteral Drugs Revenue (US$ Million) Market Share (2016-2021) Table 32. Global Parenteral Drugs Price (USD/Unit) (2016-2021) Table 33. Global Parenteral Drugs Sales (K Units) (2022-2027) Table 34. Global Parenteral Drugs Sales Share (2022-2027) Table 35. Global Parenteral Drugs Revenue (US$ Million) Market Share (2022-2027) Table 36. Global Parenteral Drugs Revenue Share (2022-2027) Table 37. Global Parenteral Drugs Price (USD/Unit) (2022-2027) Table 38. North America Parenteral Drugs Sales (K Units) by Company (2016-2021) Table 39. North America Parenteral Drugs Sales Market Share by Company (2016-2021) Table 40. North America Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Parenteral Drugs Revenue Market Share by Company (2016-2021) Table 42. North America Parenteral Drugs Sales (2016-2021) & (K Units) Table 43. North America Parenteral Drugs Sales Market Share (2016-2021) Table 44. North America Parenteral Drugs Sales (2022-2027) & (K Units) Table 45. North America Parenteral Drugs Sales Market Share (2022-2027) Table 46. North America Parenteral Drugs Sales (2016-2021) & (K Units) Table 47. North America Parenteral Drugs Sales Market Share (2016-2021) Table 48. North America Parenteral Drugs Sales (2022-2027) & (K Units) Table 49. North America Parenteral Drugs Sales Market Share (2022-2027) Table 50. Europe Parenteral Drugs Sales (K Units) by Company (2016-2021) Table 51. Europe Parenteral Drugs Sales Market Share by Company (2016-2021) Table 52. Europe Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Parenteral Drugs Revenue Market Share by Company (2016-2021) Table 54. Europe Parenteral Drugs Sales (2016-2021) & (K Units) Table 55. Europe Parenteral Drugs Sales Market Share (2016-2021) Table 56. Europe Parenteral Drugs Sales (2022-2027) & (K Units) Table 57. Europe Parenteral Drugs Sales Market Share (2022-2027) Table 58. Europe Parenteral Drugs Sales (2016-2021) & (K Units) Table 59. Europe Parenteral Drugs Sales Market Share (2016-2021) Table 60. Europe Parenteral Drugs Sales (2022-2027) & (K Units) Table 61. Europe Parenteral Drugs Sales Market Share (2022-2027) Table 62. China Parenteral Drugs Sales (K Units) by Company (2016-2021) Table 63. China Parenteral Drugs Sales Market Share by Company (2016-2021) Table 64. China Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million) Table 65. China Parenteral Drugs Revenue Market Share by Company (2016-2021) Table 66. China Parenteral Drugs Sales (2016-2021) & (K Units) Table 67. China Parenteral Drugs Sales Market Share (2016-2021) Table 68. China Parenteral Drugs Sales (2022-2027) & (K Units) Table 69. China Parenteral Drugs Sales Market Share (2022-2027) Table 70. China Parenteral Drugs Sales (2016-2021) & (K Units) Table 71. China Parenteral Drugs Sales Market Share (2016-2021) Table 72. China Parenteral Drugs Sales (2022-2027) & (K Units) Table 73. China Parenteral Drugs Sales Market Share (2022-2027) Table 74. Japan Parenteral Drugs Sales (K Units) by Company (2016-2021) Table 75. Japan Parenteral Drugs Sales Market Share by Company (2016-2021) Table 76. Japan Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Parenteral Drugs Revenue Market Share by Company (2016-2021) Table 78. Japan Parenteral Drugs Sales (2016-2021) & (K Units) Table 79. Japan Parenteral Drugs Sales Market Share (2016-2021) Table 80. Japan Parenteral Drugs Sales (2022-2027) & (K Units) Table 81. Japan Parenteral Drugs Sales Market Share (2022-2027) Table 82. Japan Parenteral Drugs Sales (2016-2021) & (K Units) Table 83. Japan Parenteral Drugs Sales Market Share (2016-2021) Table 84. Japan Parenteral Drugs Sales (2022-2027) & (K Units) Table 85. Japan Parenteral Drugs Sales Market Share (2022-2027) Table 86. Southeast Asia Parenteral Drugs Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Parenteral Drugs Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Parenteral Drugs Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Parenteral Drugs Sales (2016-2021) & (K Units) Table 91. Southeast Asia Parenteral Drugs Sales Market Share (2016-2021) Table 92. Southeast Asia Parenteral Drugs Sales (2022-2027) & (K Units) Table 93. Southeast Asia Parenteral Drugs Sales Market Share (2022-2027) Table 94. Southeast Asia Parenteral Drugs Sales (2016-2021) & (K Units) Table 95. Southeast Asia Parenteral Drugs Sales Market Share (2016-2021) Table 96. Southeast Asia Parenteral Drugs Sales (2022-2027) & (K Units) Table 97. Southeast Asia Parenteral Drugs Sales Market Share (2022-2027) Table 98. India Parenteral Drugs Sales (K Units) by Company (2016-2021) Table 99. India Parenteral Drugs Sales Market Share by Company (2016-2021) Table 100. India Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million) Table 101. India Parenteral Drugs Revenue Market Share by Company (2016-2021) Table 102. India Parenteral Drugs Sales (2016-2021) & (K Units) Table 103. India Parenteral Drugs Sales Market Share (2016-2021) Table 104. India Parenteral Drugs Sales (2022-2027) & (K Units) Table 105. India Parenteral Drugs Sales Market Share (2022-2027) Table 106. India Parenteral Drugs Sales (2016-2021) & (K Units) Table 107. India Parenteral Drugs Sales Market Share (2016-2021) Table 108. India Parenteral Drugs Sales (2022-2027) & (K Units) Table 109. India Parenteral Drugs Sales Market Share (2022-2027) Table 110. Ostuka Pharmaceutical Corporation Information Table 111. Ostuka Pharmaceutical Description and Business Overview Table 112. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. Ostuka Pharmaceutical Parenteral Drugs Product Table 114. Ostuka Pharmaceutical Recent Development Table 115. Teva Pharmaceutical Industries Corporation Information Table 116. Teva Pharmaceutical Industries Description and Business Overview Table 117. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. Teva Pharmaceutical Industries Parenteral Drugs Product Table 119. Teva Pharmaceutical Industries Recent Development Table 120. Kelun Pharma Corporation Information Table 121. Kelun Pharma Description and Business Overview Table 122. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. Kelun Pharma Parenteral Drugs Product Table 124. Kelun Pharma Recent Development Table 125. Cook Pharmica Corporation Information Table 126. Cook Pharmica Description and Business Overview Table 127. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Cook Pharmica Parenteral Drugs Product Table 129. Cook Pharmica Recent Development Table 130. Patheon Corporation Information Table 131. Patheon Description and Business Overview Table 132. Patheon Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Patheon Parenteral Drugs Product Table 134. Patheon Recent Development Table 135. BAG Healthcare Corporation Information Table 136. BAG Healthcare Description and Business Overview Table 137. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. BAG Healthcare Parenteral Drugs Product Table 139. BAG Healthcare Recent Development Table 140. Beximco Pharma Corporation Information Table 141. Beximco Pharma Description and Business Overview Table 142. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Beximco Pharma Parenteral Drugs Product Table 144. Beximco Pharma Recent Development Table 145. Baxter Healthcare Corporation Corporation Information Table 146. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Baxter Healthcare Corporation Description and Business Overview Table 148. Baxter Healthcare Corporation Parenteral Drugs Product Table 149. Baxter Healthcare Corporation Recent Development Table 150. B. Braun Corporation Information Table 151. B. Braun Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. B. Braun Description and Business Overview Table 153. B. Braun Parenteral Drugs Product Table 154. B. Braun Recent Development Table 155. Fresenius Corporation Information Table 156. Fresenius Description and Business Overview Table 157. Fresenius Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 158. Fresenius Parenteral Drugs Product Table 159. Fresenius Recent Development Table 160. Albert David Corporation Information Table 161. Albert David Description and Business Overview Table 162. Albert David Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 163. Albert David Parenteral Drugs Product Table 164. Albert David Recent Development Table 165. BML Parenteral Drugs Corporation Information Table 166. BML Parenteral Drugs Description and Business Overview Table 167. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 168. BML Parenteral Drugs Parenteral Drugs Product Table 169. BML Parenteral Drugs Recent Development Table 170. Pfizer (Hospira) Corporation Information Table 171. Pfizer (Hospira) Description and Business Overview Table 172. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 173. Pfizer (Hospira) Parenteral Drugs Product Table 174. Pfizer (Hospira) Recent Development Table 175. Pisa Corporation Information Table 176. Pisa Description and Business Overview Table 177. Pisa Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 178. Pisa Parenteral Drugs Product Table 179. Pisa Recent Development Table 180. Ozon Pharmaceuticals Ltd Corporation Information Table 181. Ozon Pharmaceuticals Ltd Description and Business Overview Table 182. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 183. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Table 184. Ozon Pharmaceuticals Ltd Recent Development Table 185. Aspen Holdings Corporation Information Table 186. Aspen Holdings Description and Business Overview Table 187. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 188. Aspen Holdings Parenteral Drugs Product Table 189. Aspen Holdings Recent Development Table 190. PSI Ltd Corporation Information Table 191. PSI Ltd Description and Business Overview Table 192. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 193. PSI Ltd Parenteral Drugs Product Table 194. PSI Ltd Recent Development Table 195. Wintac Limited Corporation Information Table 196. Wintac Limited Description and Business Overview Table 197. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 198. Wintac Limited Parenteral Drugs Product Table 199. Wintac Limited Recent Development Table 200. AXA Parenterals Ltd Corporation Information Table 201. AXA Parenterals Ltd Description and Business Overview Table 202. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 203. AXA Parenterals Ltd Parenteral Drugs Product Table 204. AXA Parenterals Ltd Recent Development Table 205. Acebright Corporation Information Table 206. Acebright Description and Business Overview Table 207. Acebright Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 208. Acebright Parenteral Drugs Product Table 209. Acebright Recent Development Table 210. Southwest Pharmaceutical Corporation Information Table 211. Southwest Pharmaceutical Description and Business Overview Table 212. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 213. Southwest Pharmaceutical Parenteral Drugs Product Table 214. Southwest Pharmaceutical Recent Development Table 215. Abbott Corporation Information Table 216. Abbott Description and Business Overview Table 217. Abbott Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 218. Abbott Parenteral Drugs Product Table 219. Abbott Recent Development Table 220. Production Base and Market Concentration Rate of Raw Material Table 221. Key Suppliers of Raw Materials Table 222. Parenteral Drugs Distributors List Table 223. Parenteral Drugs Customers List Table 224. Parenteral Drugs Market Trends Table 225. Parenteral Drugs Market Drivers Table 226. Parenteral Drugs Market Challenges Table 227. Parenteral Drugs Market Restraints Table 228. Research Programs/Design for This Report Table 229. Key Data Information from Secondary Sources Table 230. Key Data Information from Primary Sources List of Figures Figure 1. Parenteral Drugs Product Picture Figure 2. Global Parenteral Drugs Sales Market Share in 2021 & 2027 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Parenteral Drugs Sales Market Share in 2021 & 2027 Figure 6. Hospitals Examples Figure 7. Medical Centers Examples Figure 8. Others Examples Figure 9. Global Parenteral Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Parenteral Drugs Sales Growth Rate (2016-2027) & (US$ Million) Figure 11. Global Parenteral Drugs Sales (K Units) Growth Rate (2016-2027) Figure 12. Global Parenteral Drugs Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 13. Global Parenteral Drugs Revenue Market Share by Region: 2016 VS 2021 Figure 14. Global Parenteral Drugs Revenue Market Share by Region: 2021 VS 2027 Figure 15. North America Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 16. North America Parenteral Drugs Sales (K Units) Growth Rate (2016-2027) Figure 17. Europe Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 18. Europe Parenteral Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 19. China Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 20. China Parenteral Drugs Sales (Million USD) and Growth Rate (2016-2027) Figure 21. Japan Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 22. Japan Parenteral Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 24. Southeast Asia Parenteral Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 25. India Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 26. India Parenteral Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 27. Global 5 Largest Parenteral Drugs Players Market Share by Revenue in Parenteral Drugs: 2016 & 2020 Figure 28. Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 29. Global Parenteral Drugs Revenue Share (2016-2021) Figure 30. Global Parenteral Drugs Revenue Growth Rate in 2016 & 2020 Figure 31. Global Parenteral Drugs Revenue Share (2016-2021) Figure 32. Global Parenteral Drugs Revenue Growth Rate in 2016 & 2020 Figure 33. North America Parenteral Drugs Sales Market Share in 2020 Figure 34. North America Parenteral Drugs Sales Market Share in 2020 Figure 35. Europe Parenteral Drugs Sales Market Share in 2020 Figure 36. Europe Parenteral Drugs Sales Market Share in 2020 Figure 37. China Parenteral Drugs Sales Market Share in 2020 Figure 38. China Parenteral Drugs Sales Market Share in 2020 Figure 39. Japan Parenteral Drugs Sales Market Share in 2020 Figure 40. Japan Parenteral Drugs Sales Market Share in 2020 Figure 41. Southeast Asia Parenteral Drugs Sales Market Share in 2020 Figure 42. Southeast Asia Parenteral Drugs Sales Market Share in 2020 Figure 43. India Parenteral Drugs Sales Market Share in 2020 Figure 44. India Parenteral Drugs Sales Market Share in 2020 Figure 45. Key Raw Materials Price Trend Figure 46. Manufacturing Cost Structure of Parenteral Drugs Figure 47. Manufacturing Process Analysis of Parenteral Drugs Figure 48. Parenteral Drugs Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed
Ostuka Pharmaceutical Teva Pharmaceutical Industries Kelun Pharma Cook Pharmica Patheon BAG Healthcare Beximco Pharma Baxter Healthcare Corporation B. Braun Fresenius Albert David BML Parenteral Drugs Pfizer (Hospira) Pisa Ozon Pharmaceuticals Ltd Aspen Holdings PSI Ltd Wintac Limited AXA Parenterals Ltd Acebright Southwest Pharmaceutical Abbott
The global Aspiration and Biopsy Needles market is segmented by company, region (country), , and ... Read More
The global Metal Implants and Medical Alloys market is segmented by company, region (country), , ... Read More
The global Tubing Bundles market is segmented by company, region (country), , and . Players, stak ... Read More
The global Food Processing and Handling Equipment market is segmented by company, region (country ... Read More